Orchard Therapeutics ^Companies

Orchard Therapeutics is an organization that focuses on developing HSC gene therapy to transform the lives of individuals with severe genetic diseases. They are motivated by the stories and families affected by these diseases. With a platform built on decades of research, Orchard Therapeutics aims to apply their HSC gene therapy to areas of significant medical need, leveraging its distinct therapeutic advantages. The organization is committed to changing the treatment paradigm for patients with severe genetic diseases. Led by CEO Bobby Gaspar, Orchard Therapeutics is dedicated to reaching new heights and looking to new horizons in 2022.